Satellos Bioscience Financial Overview
Satellos Bioscience's market cap is currently $90.32M. The company's EPS TTM is $-0.030519804000000005; its P/E ratio is -3.67; Satellos Bioscience is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.
